The diagnostic market is evolving rapidly, with laboratories increasingly seeking automation to improve efficiency and reliability. One of the key trends in this shift is the automation of faecal sample testing, driven by the growing demand for specific biomarkers such as Calprotectin and Helicobacter pylori (H. pylori). The demand for these tests is growing rapidly and plays a crucial role in gastrointestinal disease diagnosis, making streamlined processing a priority for many labs.
A significant concern in faecal diagnostics is sample handling and crosscontamination when using other nondedicated analysers that can lead to erroneous results. To mitigate this risk, many laboratories are now opting for dedicated analysers for stool samples. This approach enhances accuracy, reduces contamination risks and improves workflow efficiency.
Certest Biotec recognises these evolving needs and has developed a CLIA (Chemiluminescence immunoassay) solution, the most sensitive immunodiagnostic technique available. The company’s system is based on CLIA Flash sandwich technology, ensuring the highest levels of sensitivity and specificity for faecal sample analysis. With this advanced approach, even low concentrations of biomarkers can be accurately detected, providing unmatched diagnostic confidence.
In addition to superior performance, Certest Biotec’s CLIA solution offers full automation, guaranteeing consistency and reliability in every test. Moreover, its compact design makes it an excellent fit for laboratories where optimising space is essential. By integrating automation, minimising contamination risks and offering the highest sensitivity and specificity, our CLIA solution provides a smart, efficient and convenient option for modern diagnostic laboratories.
